Paper31367244
A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep.
Li Y and 15 others. Theranostics, 2019. Cited by 90 papers, by iCite.
Cite this record
ConductScience Library. A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep. Papers, record 31367244. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31367244
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenosine | Major topic |
| Breast Neoplasms | Major topic |
| Cytoskeletal Proteins | Major topic |
| Epigenomics | Major topic |
| Glioblastoma | Major topic |
| Organic Chemicals | Major topic |
| Polycomb Repressive Complex 2 | Major topic |
| RNA, Long Noncoding | Major topic |
| Animals | |
| Benzofurans | |
| Enhancer of Zeste Homolog 2 Protein | |
| Female | |
| High-Throughput Screening Assays | |
| Humans | |
| Mice, Inbred BALB C | |
| Molecular Docking Simulation | |
| beta Catenin |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10021369 | Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor. | Curr Biol | 1999 | https://conductscience.org/library/papers/10021369 | PubMed |
| 2 | 12374981 | The polycomb group protein EZH2 is involved in progression of prostate cancer. | Nature | 2002 | https://conductscience.org/library/papers/12374981 | PubMed |
| 3 | 12908548 | Cancer epigenetics: DNA methylation and chromatin alterations in human cancer. | Adv Exp Med Biol | 2003 | https://conductscience.org/library/papers/12908548 | PubMed |
| 4 | 14500907 | EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/14500907 | PubMed |
| 5 | 17437993 | Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. | Genes Dev | 2007 | https://conductscience.org/library/papers/17437993 | PubMed |
| 6 | 17604720 | Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. | Cell | 2007 | https://conductscience.org/library/papers/17604720 | PubMed |
| 7 | 18951091 | Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. | Mol Cell | 2008 | https://conductscience.org/library/papers/18951091 | PubMed |
| 8 | 19345089 | Biochemical mechanisms of gene regulation by polycomb group protein complexes. | Curr Opin Genet Dev | 2009 | https://conductscience.org/library/papers/19345089 | PubMed |
| 9 | 19509260 | DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. | Mol Cancer Ther | 2009 | https://conductscience.org/library/papers/19509260 | PubMed |
| 10 | 19638619 | Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. | Blood | 2009 | https://conductscience.org/library/papers/19638619 | PubMed |
| 11 | 20393566 | Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. | Nature | 2010 | https://conductscience.org/library/papers/20393566 | PubMed |
| 12 | 20616235 | Long noncoding RNA as modular scaffold of histone modification complexes. | Science | 2010 | https://conductscience.org/library/papers/20616235 | PubMed |
| 13 | 21076461 | β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation. | Mod Pathol | 2011 | https://conductscience.org/library/papers/21076461 | PubMed |
| 14 | 21123648 | Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. | Genes Dev | 2010 | https://conductscience.org/library/papers/21123648 | PubMed |
| 15 | 21172659 | Genome-wide identification of polycomb-associated RNAs by RIP-seq. | Mol Cell | 2010 | https://conductscience.org/library/papers/21172659 | PubMed |
| 16 | 21862635 | Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. | Cancer Res | 2011 | https://conductscience.org/library/papers/21862635 | PubMed |
| 17 | 21898546 | The Wnt/β-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer. | J Cell Biochem | 2012 | https://conductscience.org/library/papers/21898546 | PubMed |
| 18 | 21963238 | Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. | Mol Cell | 2011 | https://conductscience.org/library/papers/21963238 | PubMed |
| 19 | 22614017 | HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. | Oncogene | 2013 | https://conductscience.org/library/papers/22614017 | PubMed |
| 20 | 22622284 | Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells. | Mol Cancer Ther | 2012 | https://conductscience.org/library/papers/22622284 | PubMed |
Cited by70
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42974449 | Microbial metabolites in tumor epigenetic regulation. | Imeta | 2026 | https://conductscience.org/library/papers/42974449 | PubMed |
| 42840278 | Epigenetic mechanisms of plasticity and resistance in glioblastoma: therapeutic targets and implications. | Front Epigenet Epigenom | 2025 | https://conductscience.org/library/papers/42840278 | PubMed |
| 42491964 | lncRNA HOTAIR in Cancer: Recent Advances and Critical Perspectives on Molecular Mechanisms. | Cancer Manag Res | 2026 | https://conductscience.org/library/papers/42491964 | PubMed |
| 42180858 | Construction of an actin cytoskeleton-related gene signature for predicting prognosis and therapeutic response in glioblastoma: based on machine learning. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42180858 | PubMed |
| 41596492 | RNA-Based Therapeutic Strategies in Multiple Myeloma: From Molecular Targets to Delivery and Clinical Translation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596492 | PubMed |
| 41569464 | The CeRNA role of HOTAIR: sponging MiRs to promote chemoresistance. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/41569464 | PubMed |
| 41186719 | Epigenetic regulation of EZH2 by ncRNAs: mechanisms and oncogenic implications. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41186719 | PubMed |
| 41128896 | Exploring the role of EZH2 in neuroinflammation: implications for innovative therapeutic strategies. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41128896 | PubMed |
| 41080763 | Long non-coding RNAs in B-cell acute lymphoblastic leukemia: Disease implication, challenges and therapeutic opportunities. | Noncoding RNA Res | 2026 | https://conductscience.org/library/papers/41080763 | PubMed |
| 40951838 | Non-coding RNAs as novel biomarkers and therapeutic targets in breast cancer. | Oncol Rev | 2025 | https://conductscience.org/library/papers/40951838 | PubMed |
| 40869316 | Vitamin D as an Epigenetic Regulator: A Hypothetical Mechanism for Cancer Prevention via Inhibition of Oncogenic lncRNA HOTAIR. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40869316 | PubMed |
| 40565099 | Epigenetic Alterations in Glioblastoma Multiforme as Novel Therapeutic Targets: A Scoping Review. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40565099 | PubMed |
| 39776536 | Exploring oncogenic roles and clinical significance of EZH2: focus on non-canonical activities. | Ther Adv Med Oncol | 2025 | https://conductscience.org/library/papers/39776536 | PubMed |
| 39702144 | HOTAIR in cancer: diagnostic, prognostic, and therapeutic perspectives. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/39702144 | PubMed |
| 39301658 | Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review). | Int J Mol Med | 2024 | https://conductscience.org/library/papers/39301658 | PubMed |
| 39280246 | Regulatory RNAs: role as scaffolds assembling protein complexes and their epigenetic deregulation. | Explor Target Antitumor Ther | 2024 | https://conductscience.org/library/papers/39280246 | PubMed |
| 39114502 | Strategy of combining CDK4/6 inhibitors with other therapies and mechanisms of resistance. | Int J Clin Exp Pathol | 2024 | https://conductscience.org/library/papers/39114502 | PubMed |
| 39015773 | Glioblastoma stem cell long non-coding RNAs: therapeutic perspectives and opportunities. | Front Genet | 2024 | https://conductscience.org/library/papers/39015773 | PubMed |
| 38773970 | CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma. | Theranostics | 2024 | https://conductscience.org/library/papers/38773970 | PubMed |
| 38682637 | The multifaceted functions of long non-coding RNA HOTAIR in neuropathologies and its potential as a prognostic marker and therapeutic biotarget. | Expert Rev Mol Med | 2024 | https://conductscience.org/library/papers/38682637 | PubMed |
Genes36
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31367244
GET https://conductscience.org/api/papers/v1/31367244/references?page=2